Immunotherapy

Early Use of Higher-Efficacy Therapies Recommended for Moderate-to-Severe Crohn Disease

Physician’s Briefing

Early Use of Higher-Efficacy Therapies Recommended for Moderate-to-Severe Crohn Disease

26 Nov 2025

1 min read

FDA Approves Darzalex Faspro for High-Risk Smoldering Multiple Myeloma

Physician’s Briefing

FDA Approves Darzalex Faspro for High-Risk Smoldering Multiple Myeloma

13 Nov 2025

1 min read

Dupilumab Reduces Mucus Plug Scores With Moderate-to-Severe Asthma

Physician’s Briefing

Dupilumab Reduces Mucus Plug Scores With Moderate-to-Severe Asthma

03 Nov 2025

2 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com